Bristol-Myers Squibb
BMY
#174
Rank
NZ$209.84 B
Marketcap
NZ$102.78
Share price
5.21%
Change (1 day)
22.66%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.96

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$5.87. an increase over its 2024 EPS that were of NZ-$7.50.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025NZ$5.85-178.05%
2024NZ-$7.50-213.92%
2023NZ$6.5830.2%
2022NZ$5.05-6.04%
2021NZ$5.38-179.29%
2020NZ-$6.79-281%
2019NZ$3.75-27.06%
2018NZ$5.14
2016NZ$4.53175.26%
2015NZ$1.65-19.83%
2014NZ$2.05-22.44%
2013NZ$2.6534.48%
2012NZ$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.89 221.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.21 108.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-60.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.06-30.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.06 565.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.31 314.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.50-40.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$14.98 155.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.40 111.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.06 71.39%๐Ÿ‡ฌ๐Ÿ‡ง UK